318 related articles for article (PubMed ID: 24091326)
1. Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.
Cheng JC; Bai A; Beckham TH; Marrison ST; Yount CL; Young K; Lu P; Bartlett AM; Wu BX; Keane BJ; Armeson KE; Marshall DT; Keane TE; Smith MT; Jones EE; Drake RR; Bielawska A; Norris JS; Liu X
J Clin Invest; 2013 Oct; 123(10):4344-58. PubMed ID: 24091326
[TBL] [Abstract][Full Text] [Related]
2. Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer.
Mahdy AE; Cheng JC; Li J; Elojeimy S; Meacham WD; Turner LS; Bai A; Gault CR; McPherson AS; Garcia N; Beckham TH; Saad A; Bielawska A; Bielawski J; Hannun YA; Keane TE; Taha MI; Hammouda HM; Norris JS; Liu X
Mol Ther; 2009 Mar; 17(3):430-8. PubMed ID: 19107118
[TBL] [Abstract][Full Text] [Related]
3. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
Roh JL; Park JY; Kim EH; Jang HJ
Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
[TBL] [Abstract][Full Text] [Related]
4. Acid ceramidase is upregulated in AML and represents a novel therapeutic target.
Tan SF; Liu X; Fox TE; Barth BM; Sharma A; Turner SD; Awwad A; Dewey A; Doi K; Spitzer B; Shah MV; Morad SA; Desai D; Amin S; Zhu J; Liao J; Yun J; Kester M; Claxton DF; Wang HG; Cabot MC; Schuchman EH; Levine RL; Feith DJ; Loughran TP
Oncotarget; 2016 Dec; 7(50):83208-83222. PubMed ID: 27825124
[TBL] [Abstract][Full Text] [Related]
5. Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction.
Hadas Y; Vincek AS; Youssef E; Żak MM; Chepurko E; Sultana N; Sharkar MTK; Guo N; Komargodski R; Kurian AA; Kaur K; Magadum A; Fargnoli A; Katz MG; Hossain N; Kenigsberg E; Dubois NC; Schadt E; Hajjar R; Eliyahu E; Zangi L
Circulation; 2020 Mar; 141(11):916-930. PubMed ID: 31992066
[TBL] [Abstract][Full Text] [Related]
6. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells.
Morad SA; Levin JC; Tan SF; Fox TE; Feith DJ; Cabot MC
Biochim Biophys Acta; 2013 Dec; 1831(12):1657-64. PubMed ID: 23939396
[TBL] [Abstract][Full Text] [Related]
7. Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy.
Liu X; Cheng JC; Turner LS; Elojeimy S; Beckham TH; Bielawska A; Keane TE; Hannun YA; Norris JS
Expert Opin Ther Targets; 2009 Dec; 13(12):1449-58. PubMed ID: 19874262
[TBL] [Abstract][Full Text] [Related]
8. Increased acid ceramidase expression depends on upregulation of androgen-dependent deubiquitinases, USP2, in a human prostate cancer cell line, LNCaP.
Mizutani N; Inoue M; Omori Y; Ito H; Tamiya-Koizumi K; Takagi A; Kojima T; Nakamura M; Iwaki S; Nakatochi M; Suzuki M; Nozawa Y; Murate T
J Biochem; 2015 Oct; 158(4):309-19. PubMed ID: 25888580
[TBL] [Abstract][Full Text] [Related]
9. Potential role of acid ceramidase in conversion of cytostatic to cytotoxic end-point in pancreatic cancer cells.
Morad SA; Messner MC; Levin JC; Abdelmageed N; Park H; Merrill AH; Cabot MC
Cancer Chemother Pharmacol; 2013 Mar; 71(3):635-45. PubMed ID: 23263160
[TBL] [Abstract][Full Text] [Related]
10. Acid ceramidase as a therapeutic target in metastatic prostate cancer.
Camacho L; Meca-Cortés O; Abad JL; García S; Rubio N; Díaz A; Celià-Terrassa T; Cingolani F; Bermudo R; Fernández PL; Blanco J; Delgado A; Casas J; Fabriàs G; Thomson TM
J Lipid Res; 2013 May; 54(5):1207-20. PubMed ID: 23423838
[TBL] [Abstract][Full Text] [Related]
11. Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION.
Realini N; Palese F; Pizzirani D; Pontis S; Basit A; Bach A; Ganesan A; Piomelli D
J Biol Chem; 2016 Jan; 291(5):2422-34. PubMed ID: 26553872
[TBL] [Abstract][Full Text] [Related]
12. Autophagy is increased in prostate cancer cells overexpressing acid ceramidase and enhances resistance to C6 ceramide.
Turner LS; Cheng JC; Beckham TH; Keane TE; Norris JS; Liu X
Prostate Cancer Prostatic Dis; 2011 Mar; 14(1):30-7. PubMed ID: 21116286
[TBL] [Abstract][Full Text] [Related]
13. HZ08 suppresses RelB-activated MnSOD expression and enhances Radiosensitivity of prostate Cancer cells.
Zhang Y; Xu Z; Ding J; Tan C; Hu W; Li Y; Huang W; Xu Y
J Exp Clin Cancer Res; 2018 Jul; 37(1):174. PubMed ID: 30053873
[TBL] [Abstract][Full Text] [Related]
14. The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy.
Saad AF; Meacham WD; Bai A; Anelli V; Elojeimy S; Mahdy AE; Turner LS; Cheng J; Bielawska A; Bielawski J; Keane TE; Obeid LM; Hannun YA; Norris JS; Liu X
Cancer Biol Ther; 2007 Sep; 6(9):1455-60. PubMed ID: 17881906
[TBL] [Abstract][Full Text] [Related]
15. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
16. Acid ceramidase promotes nuclear export of PTEN through sphingosine 1-phosphate mediated Akt signaling.
Beckham TH; Cheng JC; Lu P; Marrison ST; Norris JS; Liu X
PLoS One; 2013; 8(10):e76593. PubMed ID: 24098536
[TBL] [Abstract][Full Text] [Related]
17. Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B.
Beckham TH; Lu P; Cheng JC; Zhao D; Turner LS; Zhang X; Hoffman S; Armeson KE; Liu A; Marrison T; Hannun YA; Liu X
Int J Cancer; 2012 Nov; 131(9):2034-43. PubMed ID: 22322590
[TBL] [Abstract][Full Text] [Related]
18. DMAPT inhibits NF-κB activity and increases sensitivity of prostate cancer cells to X-rays in vitro and in tumor xenografts in vivo.
Mendonca MS; Turchan WT; Alpuche ME; Watson CN; Estabrook NC; Chin-Sinex H; Shapiro JB; Imasuen-Williams IE; Rangel G; Gilley DP; Huda N; Crooks PA; Shapiro RH
Free Radic Biol Med; 2017 Nov; 112():318-326. PubMed ID: 28782644
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of neurotensin receptor 1 selectively sensitizes prostate cancer to ionizing radiation.
Valerie NC; Casarez EV; Dasilva JO; Dunlap-Brown ME; Parsons SJ; Amorino GP; Dziegielewski J
Cancer Res; 2011 Nov; 71(21):6817-26. PubMed ID: 21903767
[TBL] [Abstract][Full Text] [Related]
20. Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling.
Nambiar DK; Rajamani P; Deep G; Jain AK; Agarwal R; Singh RP
Mol Cancer Ther; 2015 Dec; 14(12):2722-34. PubMed ID: 26516160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
